首页|基于回顾队列设计中医与中医联合抗微生物药治疗肺炎的比较效果研究

基于回顾队列设计中医与中医联合抗微生物药治疗肺炎的比较效果研究

Comparative effectiveness research of Chinese medicine and integrated Chinese medicine and antimicrobial drugs in the treatment of pneumonia:a retrospective cohort study design

扫码查看
目的 采用回顾性队列研究比较中医与中医联合抗微生物药治疗肺炎患者的临床疗效.方法 回顾性收集广东省中医院中医经典科2012年11月29日至2022年6月17日收治住院肺炎患者的电子病历记录,根据是否在中医治疗基础上合并使用抗微生物药治疗分为两组,非暴露组为中医组,暴露组为中医联合抗微生物药组.采用倾向性评分匹配法平衡可能的混杂因素,对匹配后的队列进行COX回归分析比较两组肺炎患者发生死亡事件的风险,并绘制Kaplan-Meier曲线评估两组的生存概率;此外还比较了两组最高氧疗浓度和退热时长.结果 共纳入898例患者,轻中度患者占比超95%.经倾向性评分匹配后,两组各纳入180例,基线特征具有可比性.主要结局指标显示,中医联合抗微生物药组住院期间发生死亡事件的风险略高于中医组[HR=1.52,95%CI(0.36,6.39),P=0.566],亚组分析与整体结果趋势一致,差异无统计学意义,提示住院期间,整体和各病情程度上两组死亡率接近.两组在主要症状(发热、咳嗽、咳痰、乏力、气促和胸痛)消失率的治疗效果上表现相似.次要结局指标显示,两组在最高氧疗浓度使用和稳定退热时长上差异无统计学意义.结论 在以轻中度为主的肺炎患者治疗上,中医组与中医联合抗微生物药组在住院期间死亡率、主要症状消失率、最高氧疗浓度和稳定退热时长等关键指标上的表现相近,合理应用中医药在减少抗微生物药使用上具有积极意义.
Objective To compare the clinical effectiveness of Chinese medicine with that of integrated Chinese medicine and antimicrobial drugs in the treatment of pneumonia.Methods The electronic medical record(EMR)of patients with pneumonia who were admitted to the Classical Department of Chinese Medicine of Guangdong Hospital of Traditional Chinese Medicine from November 29,2012 to June 17,2022 were retrospectively collected.The patients were divided into two groups according to whether they were treated with antimicrobial drugs on the basis of Chinese medicine treatment.The non-exposed group was the traditional Chinese medicine group,and the exposed group was the integrated Chinese medicine and antimicrobial drugs group.Propensity score matching method was used to balance possible confounding factors.COX regression analysis was performed on the matched cohort to compare death rates among the groups,and Kaplan-Meier curve was drawn to evaluate the survival probability during hospitalization.The proportion of maximum oxygen concentration and duration of fever remission were compared between the two groups.Results This study included a total of 898 cases,with the majority(over 95%)falling within the range of mild to moderate severity.After propensity score matching,180 patients remained in each group,among whom the baseline characteristics were comparable.The primary outcome indicators showed that the risk of death during hospitalization was same in the integrated Chinese medicine and antimicrobial drugs group and in the Chinese medicine group(HR=1.52,95%CI 0.36 to 6.39,P=0.566),the subgroup analysis was consistent with the overall trend of the results,and the differences were not statistically significant.The results indicate that during the hospitalization,the overall and subgroup mortality rates were similar between the two groups.The treatment effectiveness on the disappearance of major symptoms such as fever,cough,sputum production,fatigue,shortness of breath,and chest pain were comparable in both groups.The secondary outcome indicators showed that there was no statistical significance in the comparison of the proportion of maximum oxygen therapy concentration and the stable duration of fever remission between the two groups.Conclusion In the treatment of patients with mainly mild to moderate pneumonia,the effectiveness of the Chinese medicine group and the integrated Chinese medicine and antimicrobial drugs group in the hospitalization mortality,the disappearance of major symptoms,the proportion of maximum oxygen therapy concentration and the stable duration of fever remission are similar.Chinese medicine has a positive significance in reducing the use of antimicrobials in patients with pneumonia.

PneumoniaChinese medicineIntegrated Chinese and Western medicineRetrospective cohort study

周小文、黄遂和、蔡坚雄、黄臻、谢倩文、谢庆凤、孙良生、杨志敏、吴大嵘、颜芳

展开 >

广州中医药大学第二临床医学院(广州 510405)

广州中医药大学第二附属医院中医经典科(广州 510145)

省部共建中医湿证国家重点实验室,广州中医药大学第二附属医院(广州 510120)

广州中医药大学第二附属医院李可古中医齐玉茹学术经验传承工作室(广州 510145)

展开 >

肺炎 中医治疗 中西医结合 回顾性队列研究

2024

中国循证医学杂志
四川大学

中国循证医学杂志

CSTPCD北大核心
影响因子:1.761
ISSN:1672-2531
年,卷(期):2024.24(12)